These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9236187)

  • 21. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    Brennan J; Mager D; Jefferies W; Takei F
    J Exp Med; 1994 Dec; 180(6):2287-95. PubMed ID: 7964501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.
    Olsson MY; Kärre K; Sentman CL
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1649-53. PubMed ID: 7878033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
    Held W; Dorfman JR; Wu MF; Raulet DH
    Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
    J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft.
    Waldenström M; Sundbäck J; Olsson-Alheim MY; Achour A; Kärre K
    Eur J Immunol; 1998 Sep; 28(9):2872-81. PubMed ID: 9754574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
    Orihuela M; Margulies DH; Yokoyama WM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11792-7. PubMed ID: 8876216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
    Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
    Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes in two major histocompatibility complex class I regions control selection, phenotype, and function of a rat Ly-49 natural killer cell subset.
    Naper C; Ryan JC; Kirsch R; Butcher GW; Rolstad B; Vaage JT
    Eur J Immunol; 1999 Jun; 29(6):2046-53. PubMed ID: 10382768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice.
    Salcedo M; Andersson M; Lemieux S; Van Kaer L; Chambers BJ; Ljunggren HG
    Eur J Immunol; 1998 Apr; 28(4):1315-21. PubMed ID: 9565371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
    Iizuka K; Scalzo AA; Xian H; Yokoyama WM
    J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice.
    Karlhofer FM; Orihuela MM; Yokoyama WM
    J Exp Med; 1995 May; 181(5):1785-95. PubMed ID: 7722455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the natural killer cell receptor repertoire.
    Raulet DH; Vance RE; McMahon CW
    Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells.
    Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG
    J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low number of H-2Dd-negative haematopoietic cells in mixed bone marrow chimeras convey in vivo tolerance to H-2Dd-negative cells but fail to prevent resistance to H-2Dd-negative leukaemia.
    Johansson MH; Höglund P
    Scand J Immunol; 2004 Jan; 59(1):71-8. PubMed ID: 14723624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ly49A expression on T cells alters T cell selection.
    Fahlén L; Oberg L; Brännström T; Khoo NK; Lendahl U; Sentman CL
    Int Immunol; 2000 Feb; 12(2):215-22. PubMed ID: 10653857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin.
    Gays F; Unnikrishnan M; Shrestha S; Fraser KP; Brown AR; Tristram CM; Chrzanowska-Lightowlers ZM; Brooks CG
    J Immunol; 2000 May; 164(10):5094-102. PubMed ID: 10799866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.